期刊文献+

半胱氨酸蛋白酶抑制剂C在原发性肝癌组织中表达的初步研究 被引量:3

Preliminary Study on the Expression of Cystatin C in Primary Liver Cancer
原文传递
导出
摘要 目的以原发性肝癌患者(未发生临床远处转移)为研究对象,对半胱氨酸蛋白酶抑制剂C(cystatin C)在原发性肝癌组织中的表达做初步研究。方法建立原发性肝癌组(n=41)、肝硬化组(n=24)和正常健康对照组(n=40)。比较肝癌组(癌组织、癌旁组织、远癌组织)与肝硬化组肝组织中cystatin C的表达,比较各组外周血中cystatin C的水平,并同时进一步就癌组织cystatin C表达强度与肿瘤大小、肝内转移情况,及血清甲胎蛋白(AFP)水平做相关性分析。结果原发性肝癌所有癌组织切片中cystatin C表达均呈阳性反应。部分癌旁组织、远癌组织和肝硬化组织切片中有不同程度cystatin C表达。秩和检验结果显示,肝组织中各组cystatin C表达差异具有统计学意义(P<0.01),cystatin C在肝组织中阳性细胞比例、染色强度和以上两者乘积的表达均为:肝癌组织>癌旁组织>肝硬化组织>远癌组织。血清cystatin C水平比较显示,原发性肝癌组与肝硬化组均高于正常健康对照组,差异具有统计学意义(P<0.001),而肝癌组与肝硬化组之间差异无统计学意义(P=0.769)。相关性分析显示,肝癌组织中cystatin C表达程度(阳性细胞比例分值,染色强度分值)同血清AFP水平、肿瘤大小、肝内转移情况无特殊相关。结论在未发生远处转移的原发性肝癌患者,癌组织中cystatin C表达增强,高于癌旁组织、肝硬化组织及远癌组织,同时血清中cystatin C水平也高于正常健康对照。因此检测组织或血中cystatin C表达水平对判断原发性肝癌不同的疾病阶段具有一定意义。 Objective To preliminarily investigate the expression of cysteine proteinase inhibitors (5 (cystatm C) in primary hepatic carcinoma. Methods Hepatic tissue samples and peripheral blood samples were collected from 41 cases of primary hepatic carcinoma, 24 cases of cirrhosis and 40 cases of normal control. To primary hepatic carcinoma, three kinds of hepatic tissue samples were harvested, including carcinoma tissue, adjacent non-tumor tissue, and distant normal tissue. The expression levels of cystatin C in hepatic samples and blood samples were measured by immunohistochemistry method and latex enhanced immune turbidimetric method respectively, and the differences of cystatin C expressions were compared in primary hepatic cancer, cirrhosis, and normal control. Furthermore, the relationships of eystatin C expression with tumor size, intrahepatic metastasis, serum AFP level were studied with correlation analysis. Results The expression of cystatin C was positive, in primary hepatic carcinoma. Part of adjacent non tumor tissue, and distant normal tissue and cirrhosis tissues had some degree of cyctatin C expression. Wilcoxon test showed that the differences of cyctatin C expression in different hepatic tissues were statistics significance (P〈0.01). The proportion of positive cell, staining intensity, and the product of these two was.. carcinoma tissues:〉 adjacent non-tumor tissues:〉 cirrhosis tissues:〉 distant normal tissue. Compared with normal control, primary hepatic carcinoma and cirrhosis both had higher serum cystatin C level (P〈0. 001), but there was no difference between hepatic carcinoma and cirrhosis (P=0. 769). The correlation analysis showed that the level of serum cystatin C was not related to serum AFP, tumor size, or intrahepatic metastasis. Conclusion The expression of cystatin C in primary hepatic carcinoma is higher than that of adjacent non tumor tissue, distant normal tissue, and cirrohsis tissue. The serum cystatin C level of primary hepatic carcinoma is higher than that of normal control.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2013年第6期920-923,共4页 Journal of Sichuan University(Medical Sciences)
基金 国家自然科学基金(No.81100303,81201343)资助
关键词 原发性肝癌 肝硬化 半胱氨酸蛋白酶抑制剂C Primary liver cancer Liver cirrhosis Cystatin C
  • 相关文献

参考文献13

  • 1Laterza OF,Price CP,Scott MG.Cystatin C:an improvedestimator of glomerular filtration rate? Clin Chem,2002 ; 48(5):699-707.
  • 2van Deventer HE,Paiker JE,Katz IJ,et al.A comparison ofcystatin C-and creatinine-based prediction equations for theestimation of glomerular filtration rate in black South Africans.Nephrol Dial Transplant,2011; 26(5):1553-1558.
  • 3Spector JT,Acien AN,Fadrowski J,et aL.Associations ofblood lead with estimated glomerular filtration rate usingMDRD * CKD-EPI and serum cystatin C-based equations.Nephrol Dial Transplant,2011;26(9):2786-2792.
  • 4Jayagopal V,Keevil BG,Atkin SL,et al.Paradoxical changesin cystatin C and serum creatinine in patients with hypo-andhyperthyroidism.Clin Chem,2003 ;49(4):680-681.
  • 5Naumnik W,Niklinska W,Ossolinska M,et al.Serumcathepvsin K and cystatin C concentration in patients withadvanced non'small-cell lung cancer during chemotherapy.Folia Histochem Cytobiol,2009 ;47(2):207-213.
  • 6Wegiel B,Jiborn 丁,Abrahamson M,et al.Cystatin C isdownregulated in prostate cancer and modulates invasion ofprostate cancer cells via MAPK/Erk and androgen receptorpathways.PLoS One,2009; 4(11):e7953.
  • 7Terpos E,Katodritou E,Tsiftsakis E,et al.Cystatin-C is anindependent prognostic factor for survival in multiple myelomaand is reduced by bortezomib administration.Haematologica,2009;94:372-379.
  • 8Boutte AM,Friedman DB,Bogyo M,et al.Identification of amyeloid-derived suppresvsor cell cystatin-like protein thatinhibits metastasis.FASEB J,2011 ;25(8); 2626-2637.
  • 9吴在德 吴肇汉.外科学第6版[M].北京:人民卫生出版社,2003.608,596.
  • 10于萍,步宏,王华,赵高平,张景丽,周桥.免疫组化结果的图像分析与人工计数方法的对比研究[J].生物医学工程学杂志,2003,20(2):288-290. 被引量:188

共引文献270

同被引文献20

  • 1王蕾,陈凌燕,刘华,高锋.半胱氨酸蛋白酶抑制剂C在胃肠道肿瘤组织中表达的研究[J].中华检验医学杂志,2006,29(12):1133-1136. 被引量:7
  • 2Tan G J, Peng Z K, Lu J P, Tang F Q. Cathepsins mediate tumor metastasis[J]. World J Biol Chem, 2013,4(4) :91 -101.
  • 3Aggarwal N, Sloane B F. Cathepsin B: multiple roles in cancer [J]. Proteomics Clin Appl, 2014,8(5-6) :427 -37.
  • 4Bian B, Mongrain S, Cagnol S, et al. Cathepsin B promotes col.or- ectal tumorigenesis, cell invasion, and metastasis [ J/OL]. Mol Carcinog, 2015. doi: 10. 1002/mc. 22312. [ Epub ahead of print ].
  • 5Swisher L Z, Prior A M, Gunaratna M J, et al. Quantitative elec- trochemical detection of cathepsin B activity in breast cancer cell lysates using carbon nanofiber nanoelectrode arrays toward identifi- cation of cancer formation [ J ]. Nanomedicine, 2015,11 (7) : 1695 - 704.
  • 6Alapati K, Kesanakurti D, Rao J S, Dasari V R. uPAR and ca- thepsin B-mediated compartmentalization of JNK regulates the mi- gration of glioma-initiating cells [ J 1. Stem Cell Res, 2014, 12 (3) :716 -29.
  • 7Ma W, Ma L, Zhe H, et al. Detection of esophageal squamous cell carcinonm by cathepsin B activity in nude mice [ J 1. PLoS One, 2014,9(3) :e92351.
  • 8Gong F, Peng X, Luo C, et al. Cathepsin B as a potential prog- nostic and therapeutic marker for human lung squamous cell carci- noma[Jl. Mol Cancer, 2013,12(20) :125.
  • 9Wu D, Wang H, Li Z, et al. Cathepsin B may be a potential bio- marker in cervical cancer [ J ]. Histol Histopathol, 2012,27 ( 1 ) : 79 - 87.
  • 10Wegiel B, .Iiborn T, Abrahamson M, et al. Cystatin C is down- regulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways [ J ]. PLoS One, 2009.4 ( 11 ) : e7953.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部